OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-8.73 Cr | ₹1.66 Cr | ₹1.46 Cr | ₹1.34 Cr | ₹1.13 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-8.73 Cr |
Mar2023 | ₹1.66 Cr |
Mar2022 | ₹1.46 Cr |
Mar2021 | ₹1.34 Cr |
Mar2020 | ₹1.13 Cr |
How is Deferred Tax Assets / Liabilities of OXYGENTA PHARMACEUTICAL Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.73 Cr | Negative | |
Mar2023 | ₹1.66 Cr | 13.55 | |
Mar2022 | ₹1.46 Cr | 9.03 | |
Mar2021 | ₹1.34 Cr | 19.01 | |
Mar2020 | ₹1.13 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹217.2 Cr | -15.8% | -17.6% | -23.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,893.0 Cr | 1% | 4.8% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹171,976.0 Cr | 11.2% | 7.4% | 10.5% | Stock Analytics | |
CIPLA | ₹126,137.0 Cr | 3.2% | -0.1% | -7.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,712.0 Cr | 0.3% | -1.6% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 1.3% | -3% | -6.5% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -15.8% |
-17.6% |
-23.5% |
SENSEX | 1.6% |
1.7% |
1.8% |
You may also like the below Video Courses